View Clinical Trial (Medical Research Study)
A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation - NCT01040637-84106(Clinical Trial 616899)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Salt Lake City |
|
State:
|
|
UT |
| Zip Code: |
|
84106 |
| Conditions: |
|
Healthy - Opioid-induced Constipation |
| Purpose: |
|
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of
TD-1211 in healthy subjects and activity in subjects with opioid-induced constipation (OIC).
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Males and females between 18 and 65 years of age, inclusive
- Healthy subjects and subjects with documented OIC on stable opioid regimen
- Willingness to stop all laxatives throughout the OIC screening and treatment period
Exclusion Criteria:
- Any clinically significant finding in healthy subjects
- Have participated in another clinical trial of an investigational drug 30 days prior
to screening
- History of chronic constipation prior to opioid therapy in OIC subjects
- Active medical disorders associated with diarrhea or intermittent loose stools in OIC
subjects |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
September 10, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|